Senior insider sale
President and CEO at INTELLIA THERAPEUTICS, INC. — senior position signals high conviction
$822.4K
88.15K shares
What this filing means
LEONARD JOHN M plans to sell 88.15K shares of INTELLIA THERAPEUTICS, INC. valued at approximately $822.4K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 12/11/2025ACC: 0001969223-25-001077
DirectorOfficer· President and CEO
Since Mar 2026
88.15K
Shares to sell
$822.4K
Approx. market value
88.15K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months3
Stock Option Exercise
Cash
12/11/2025
49.96KRestricted Vesting
N/A
1/1/2022
5.36KStock Option Exercise
Cash
4/1/2021
32.83KTotal acquired88.15K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
12/11/2025 | Stock Option Exercise Cash | 49.96K | — |
1/1/2022 | Restricted Vesting N/A | 5.36K | — |
4/1/2021 | Stock Option Exercise Cash | 32.83K | — |
| Total | 88.15K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
88.15K
Market value
$822.4K
12/11/2025
Total
Units
88.15K
Value
$822.4K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
12/11/2025 | 88.15K | $822.4K | NASDAQ | Planned |
| Total | 88.15K | $822.4K | ||